(Q74336505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

W K Hofmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

W J Kell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Fenaux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Castaigne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Ganser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Burnett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Kowal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Hoelzer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A K Burnett

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1583-1588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995004%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2401873

10 November 2019

exact match

0 references

cites work

Developmental roles of the retinoic acid receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Mechanisms of transactivation by retinoic acid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25-dihydroxyvitamin D3, and analogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

A human retinoic acid receptor which belongs to the family of nuclear receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Nuclear receptor that identifies a novel retinoic acid response pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Induction of TNF-α in patients with myelodysplastic syndromes undergoing treatment with interleukin-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Apoptosis and its significance in MDS: controversies revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

What is ineffective erythropoiesis in myelodysplastic syndromes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Impaired Proliferation and Differentiation of Myelodysplastic CD34+Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Treatment of patients with low-risk myelodysplastic syndromes using a combination of all- trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Combined differentiating therapy for myelodysplastic syndromes: a phase II study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all- trans -retinoic acid, granulocyte colony-stimulating factor, erythropoietin and α-tocopherol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Clinical use of hematopoietic growth factors in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Differentiation therapy of myelodysplastic syndromes: fact or fiction?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

1 reference

7 January 2021

Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

All-trans retinoic acid in the treatment of myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021

Therapeutic effects of low-dose cytosine arabinoside, alpha-interferon, 1 alpha-hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401873

7 January 2021